News
The Centers for Disease Control and Prevention might soon limit its guidance for who should receive a coronavirus booster ...
The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.
4d
MedPage Today on MSNEpidemiologist Reacts to CDC's Vaccine Meeting; Postpartum Mocktails; MD vs InsurerCardiologist Siyab Panhwar, MD, criticized a post on X that called doctors "algorithms" or "decision trees," emphasizing that ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
In his inaugural speech upon taking over as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr.
As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...
Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...
After the Advisory Committee on Immunization Practices (ACIP) met last week, epidemiologist Katelyn Jetelina, PhD, MPH, highlighted key moments, including "...hints of a shift toward a European ...
Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...
A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results